These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3263340)

  • 1. Stimulatory effects of bestatin on human B-cell colony formation.
    Otsuka T; Okamura S; Ohhara N; Harada M; Hayashi S; Yamaga S; Omori F; Niho Y
    Int J Immunopharmacol; 1988; 10(5):587-91. PubMed ID: 3263340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with Bestatin.
    Noma T; Klein B; Cupissol D; Yata J; Serrou B
    Int J Immunopharmacol; 1984; 6(2):87-92. PubMed ID: 6429060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro.
    Morikawa K; Morikawa S; Nakano A; Oseko F
    Int J Immunopharmacol; 1989; 11(8):905-13. PubMed ID: 2613395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of bestatin on the growth of human lymphocytes.
    Ino K; Isobe K; Goto S; Nakashima I; Tomoda Y
    Immunopharmacology; 1992; 23(3):163-71. PubMed ID: 1500283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical studies of bestatin as an immunomodulator].
    Miwa H; Oka T; Tsurumi T; Sakae Y; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1019-24. PubMed ID: 7184437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bestatin on production of granulocyte-macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro.
    Okamura S; Omori F; Haga K; Baba H; Sugimachi K; Niho Y
    Acta Oncol; 1990; 29(6):795-7. PubMed ID: 2223151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic effect of bestatin on lymphocytes.
    Ishizuka M; Sato J; Sugiyama Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Jun; 33(6):653-62. PubMed ID: 7419476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bestatin, a new immunomodulator, augments the release of mitogenic factors from PHA-stimulated human lymphocytes.
    Blomgren H
    Biomedicine; 1981 Dec; 34(4):188-92. PubMed ID: 6979352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of normal peripheral blood T- and B-cell colony-forming cells: growth factors(s) and accessory cell requirements for their in vitro proliferation.
    Georgoulias V; Marion S; Consolini R; Jasmin C
    Cell Immunol; 1985 Jan; 90(1):1-13. PubMed ID: 3871357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of B cell colonies independent of T cell contact.
    Fernandez LA; MacSween JM; Robson DA
    Immunol Lett; 1989 Aug; 22(2):167-71. PubMed ID: 2789188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bestatin (Ubenimex) on human T-cell colony formation.
    Wakabayashi Y; Hashimoto M; Saitoh K; Osawa H; Koike M; Hirose S
    Anticancer Drugs; 1991 Feb; 2(1):39-43. PubMed ID: 1835660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bestatin treatment of patients with myelodysplastic syndromes].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):365-70. PubMed ID: 2930201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.
    Suzawa T; Hyodo S; Kishi T; Kashiwa H; Karakawa T; Kittaka E; Sakano T; Usui T
    Immunology; 1984 Nov; 53(3):499-505. PubMed ID: 6333386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of mitomycin resistant T cells in peripheral blood of normal individuals.
    Fernandez LA; MacSween JM
    J Immunol Methods; 1987 Apr; 98(2):271-7. PubMed ID: 3494785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
    Schorlemmer HU; Bosslet K; Sedlacek HH
    Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation by PHA of CD8 lymphocytes into clonal colony forming cells. Role of interleukin-1.
    Oudrhiri N; Farcet JP; Gourdin MF; Divine M; Marolleau JP; Bouguet J; Le Couedic JP; Shaw A; Fradelizi D; Reyes F
    J Immunol Methods; 1988 Jun; 110(2):241-9. PubMed ID: 3132508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
    Otsuka T; Okamura S; Niho Y; Kusaba T
    J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bestatin treatment and the peripheral lymphocyte population in cancer patients.
    Blomgren H; Strender LE; Edsmyr F
    Recent Results Cancer Res; 1980; 75():133-8. PubMed ID: 7232824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.